Filing Details
- Accession Number:
- 0000904454-17-000692
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-22 11:44:05
- Reporting Period:
- 2017-11-20
- Accepted Time:
- 2017-11-22 11:44:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1070336 | Achillion Pharmaceuticals Inc | ACHN | Pharmaceutical Preparations (2834) | NJ |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
200406 | Johnson & Johnson | One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933 | No | No | Yes | No | |
924020 | Johnson & Johnson Innovation - Jjdc, Inc. | 410 George Street New Brunswick NJ 08901 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-11-20 | 18,367,346 | $2.75 | 0 | No | 4 | S | Indirect | By Johnson & Johnson Innovation - JJDC, Inc. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Johnson & Johnson Innovation - JJDC, Inc. |
Footnotes
- The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person.